Request for Covid-19 Impact Assessment of this Report
The global Breast Cancer Predictive Genetic Testing market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 High Penetrant Genes
1.2.1.2 Intermediate Penetrant Genes
1.2.1.3 Low Penetrant Genes
1.2.2 by Application
1.2.2.1 Hospitals
1.2.2.2 Clinics
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 High Penetrant Genes Market, 2013-2018
4.1.2 Intermediate Penetrant Genes Market, 2013-2018
4.1.3 Low Penetrant Genes Market, 2013-2018
4.2 Market Forecast
4.2.1 High Penetrant Genes Market Forecast, 2019-2023
4.2.2 Intermediate Penetrant Genes Market Forecast, 2019-2023
4.2.3 Low Penetrant Genes Market Forecast, 2019-2023
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospitals Market, 2013-2018
5.1.2 Clinics Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospitals Market Forecast, 2019-2023
5.2.2 Clinics Market Forecast, 2019-2023
5.2.3 Others Market Forecast, 2019-2023
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Roche
8.2 Thermo Fisher Scientific
8.3 PerkinElmer
8.4 Quest Diagnostics
8.5 Myriad Genetics
8.6 Iverson Genetics
8.7 Cancer Genetics
8.8 OncoCyte Corporation
8.9 NeoGenomics
8.10 Invitae
9 Conclusion
Table Product Specifications of Breast Cancer Predictive Genetic Testing
Table Products Segment of Breast Cancer Predictive Genetic Testing
Table High Penetrant Genes Overview
Table Intermediate Penetrant Genes Overview
Table Low Penetrant Genes Overview
Table Global Breast Cancer Predictive Genetic Testing Market by Type, 2011-2022 (USD Million)
Table Application Segment of Breast Cancer Predictive Genetic Testing
Table Hospitals Overview
Table Clinics Overview
Table Others Overview
Table Global Breast Cancer Predictive Genetic Testing Market by Application, 2011-2022 (USD Million)
Table Global Breast Cancer Predictive Genetic Testing Market by Region, 2011-2022 (USD Million)
Table Cost of Breast Cancer Predictive Genetic Testing
Table Market Dynamics
Table Policy of Breast Cancer Predictive Genetic Testing
Table GDP of Major Countries
Table High Penetrant Genes CAGR by Revenue and Volume, 2012-2018
Table Intermediate Penetrant Genes CAGR by Revenue and Volume, 2012-2018
Table Low Penetrant Genes CAGR by Revenue and Volume, 2012-2018
Table High Penetrant Genes CAGR by Revenue and Volume, 2012-2022
Table Intermediate Penetrant Genes CAGR by Revenue and Volume, 2012-2022
Table Low Penetrant Genes CAGR by Revenue and Volume, 2012-2022
Table Hospitals CAGR by Revenue and Volume, 2012-2018
Table Clinics CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Breast Cancer Predictive Genetic Testing Market by Vendors, 2012-2018 (USD Million)
Table Global Breast Cancer Predictive Genetic Testing Market by Vendors, 2012-2018 (in Volume)
Table Global Breast Cancer Predictive Genetic Testing Market Share by Vendors, 2012-2018 (USD Million)
Table Global Breast Cancer Predictive Genetic Testing Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Thermo Fisher Scientific Profile List
Table Microecological Modulator Operating Data of Thermo Fisher Scientific (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PerkinElmer Profile List
Table Microecological Modulator Operating Data of PerkinElmer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quest Diagnostics Profile List
Table Microecological Modulator Operating Data of Quest Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Myriad Genetics Profile List
Table Microecological Modulator Operating Data of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Iverson Genetics Profile List
Table Microecological Modulator Operating Data of Iverson Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cancer Genetics Profile List
Table Microecological Modulator Operating Data of Cancer Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OncoCyte Corporation Profile List
Table Microecological Modulator Operating Data of OncoCyte Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NeoGenomics Profile List
Table Microecological Modulator Operating Data of NeoGenomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Invitae Profile List
Table Microecological Modulator Operating Data of Invitae (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...